Minh Diem Vu

2.2k total citations
26 papers, 1.4k citations indexed

About

Minh Diem Vu is a scholar working on Immunology, Transplantation and Oncology. According to data from OpenAlex, Minh Diem Vu has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Transplantation and 6 papers in Oncology. Recurrent topics in Minh Diem Vu's work include Immune Cell Function and Interaction (10 papers), Renal Transplantation Outcomes and Treatments (8 papers) and T-cell and B-cell Immunology (7 papers). Minh Diem Vu is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Renal Transplantation Outcomes and Treatments (8 papers) and T-cell and B-cell Immunology (7 papers). Minh Diem Vu collaborates with scholars based in United States, Canada and Japan. Minh Diem Vu's co-authors include Li X, Wenda Gao, Nicolas Degauque, Xuemin Xu, Guang Yu, Xiang Xiao, Alexander Kroemer, Elizabeth D. Kilpatrick, Ming Chen and Naoto Ishii and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Blood.

In The Last Decade

Minh Diem Vu

26 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minh Diem Vu United States 17 848 295 290 261 238 26 1.4k
Fumin Fu United States 16 938 1.1× 128 0.4× 140 0.5× 249 1.0× 271 1.1× 27 1.5k
Majed M. Hamawy United States 24 925 1.1× 200 0.7× 586 2.0× 405 1.6× 402 1.7× 56 1.8k
Andi Qipo United States 14 789 0.9× 633 2.1× 49 0.2× 211 0.8× 365 1.5× 15 1.7k
Kimberly Marquette United States 14 333 0.4× 150 0.5× 115 0.4× 174 0.7× 236 1.0× 15 979
A. J. F. D'Apice Australia 16 364 0.4× 520 1.8× 95 0.3× 383 1.5× 369 1.6× 48 1.4k
Margherita Gigante Italy 21 362 0.4× 244 0.8× 86 0.3× 440 1.7× 116 0.5× 38 1.2k
Julian R. Pratt United Kingdom 16 894 1.1× 33 0.1× 451 1.6× 209 0.8× 370 1.6× 23 1.5k
Yinchen Dong United States 12 671 0.8× 132 0.4× 446 1.5× 220 0.8× 477 2.0× 20 1.3k
Elsie Oppermann Germany 19 184 0.2× 211 0.7× 67 0.2× 304 1.2× 146 0.6× 58 997
Milagros Lagman United States 11 292 0.3× 605 2.1× 370 1.3× 502 1.9× 440 1.8× 19 1.6k

Countries citing papers authored by Minh Diem Vu

Since Specialization
Citations

This map shows the geographic impact of Minh Diem Vu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minh Diem Vu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minh Diem Vu more than expected).

Fields of papers citing papers by Minh Diem Vu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minh Diem Vu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minh Diem Vu. The network helps show where Minh Diem Vu may publish in the future.

Co-authorship network of co-authors of Minh Diem Vu

This figure shows the co-authorship network connecting the top 25 collaborators of Minh Diem Vu. A scholar is included among the top collaborators of Minh Diem Vu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minh Diem Vu. Minh Diem Vu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seckinger, Anja, Laura Moreno, Brigitte Neuber, et al.. (2015). Target Expression, Preclinical Activity and Mechanism of Action of EM801: A Novel First-in-Class Bcma T-Cell Bispecific Antibody for the Treatment of Multiple Myeloma. Blood. 126(23). 117–117. 9 indexed citations
2.
Vicente, Javier de, Rémy C. Lemoine, Mark J. Bartlett, et al.. (2014). Scaffold hopping towards potent and selective JAK3 inhibitors: Discovery of novel C-5 substituted pyrrolopyrazines. Bioorganic & Medicinal Chemistry Letters. 24(21). 4969–4975. 20 indexed citations
3.
Jaime‐Figueroa, Saul, Javier de Vicente, Johannes C. Hermann, et al.. (2013). Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(9). 2522–2526. 31 indexed citations
4.
Xu, Daigen, Yong Kim, Jennifer Postelnek, et al.. (2012). RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents. Journal of Pharmacology and Experimental Therapeutics. 341(1). 90–103. 105 indexed citations
5.
Kroemer, Alexander, Xiang Xiao, Minh Diem Vu, et al.. (2007). OX40 Controls Functionally Different T Cell Subsets and Their Resistance to Depletion Therapy. The Journal of Immunology. 179(8). 5584–5591. 51 indexed citations
6.
Vu, Minh Diem, Xiang Xiao, Wenda Gao, et al.. (2007). OX40 costimulation turns off Foxp3+ Tregs. Blood. 110(7). 2501–2510. 323 indexed citations
7.
Vu, Minh Diem, Michael R. Clarkson, Hideo Yagita∥, et al.. (2006). Critical, but Conditional, Role of OX40 in Memory T Cell-Mediated Rejection. The Journal of Immunology. 176(3). 1394–1401. 106 indexed citations
8.
Yu, Guang, Xuemin Xu, Minh Diem Vu, Elizabeth D. Kilpatrick, & Li X. (2006). NK cells promote transplant tolerance by killing donor antigen-presenting cells. The Journal of Experimental Medicine. 203(8). 1851–1858. 211 indexed citations
9.
Vu, Minh Diem, Farhana Amanullah, Yongsheng Li, et al.. (2004). Different Costimulatory and Growth Factor Requirements for CD4+ and CD8+ T Cell-Mediated Rejection. The Journal of Immunology. 173(1). 214–221. 38 indexed citations
10.
Vu, Minh Diem & Li X. (2004). Study of T-Cell Costimulatory Blockade In Vivo at a Single-Cell Level. Humana Press eBooks. 109. 409–420. 3 indexed citations
11.
Vu, Minh Diem, Shijie Qi, Xiang Wang, et al.. (2003). Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts1 2. Transplantation. 75(9). 1455–1459. 13 indexed citations
12.
Qi, Shijie, Shengyun Zhu, Dasheng Xu, et al.. (2003). Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates1. Transplantation. 75(8). 1124–1128. 26 indexed citations
13.
Wang, Xiang, Shijie Qi, Dasheng Xu, et al.. (2002). Restoration of fertility in oophorectomized rats after tubo‐ovarian transplantation. Microsurgery. 22(1). 30–33. 19 indexed citations
14.
Tremblay, Johanne, Hui-Fang Chen, Junzheng Peng, et al.. (2002). Renal Ischemia-reperfusion injury in the rat is prevented by a novel immune modulation therapy. Transplantation. 74(10). 1425–1433. 13 indexed citations
15.
Marshansky, Vladimir, Xin Wang, Richard Bertrand, et al.. (2001). Proteasomes Modulate Balance Among Proapoptotic and Antiapoptotic Bcl-2 Family Members and Compromise Functioning of the Electron Transport Chain in Leukemic Cells. The Journal of Immunology. 166(5). 3130–3142. 101 indexed citations
16.
Chen, Huifang, Junzheng Peng, Hongyu Luo, et al.. (2000). COMPROMISED KIDNEY GRAFT REJECTION RESPONSE IN VERVET MONKEYS AFTER WITHDRAWAL OF IMMUNOSUPPRESSANTS TACROLIMUS AND SIROLIMUS1. Transplantation. 69(8). 1555–1561. 25 indexed citations
17.
Qi, Shijie, Dasheng Xu, Junzheng Peng, et al.. (2000). EFFECT OF TACROLIMUS (FK506) AND SIROLIMUS (RAPAMYCIN) MONO- AND COMBINATION THERAPY IN PROLONGATION OF RENAL ALLOGRAFT SURVIVAL IN THE MONKEY1. Transplantation. 69(7). 1275–1283. 62 indexed citations
18.
Qi, Shijie, Junzheng Peng, Dasheng Xu, et al.. (1999). Improved techniques for kidney transplantation in the monkey. Microsurgery. 19(7). 335–337. 4 indexed citations
19.
20.
Vu, Minh Diem, Shijie Qi, Dasheng Xu, et al.. (1997). TACROLIMUS (FK506) AND SIROLIMUS (RAPAMYCIN) IN COMBINATION ARE NOT ANTAGONISTIC BUT PRODUCE EXTENDED GRAFT SURVIVAL IN CARDIAC TRANSPLANTATION IN THE RAT1,2. Transplantation. 64(12). 1853–1856. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fumin Fu Breakdown of academic impact, for papers by Majed M. Hamawy Breakdown of academic impact, for papers by Andi Qipo Breakdown of academic impact, for papers by Kimberly Marquette Breakdown of academic impact, for papers by A. J. F. D'Apice Breakdown of academic impact, for papers by Margherita Gigante Breakdown of academic impact, for papers by Julian R. Pratt Breakdown of academic impact, for papers by Yinchen Dong Breakdown of academic impact, for papers by Elsie Oppermann Breakdown of academic impact, for papers by Milagros Lagman
Rankless by CCL
2026